LexaGene Life Sciences RD Investors, LLC — Form D

LexaGene Life Sciences RD Investors, LLC of DALLAS, TX, a company, filed a Form D exempt-offering notice with the SEC on 2024-03-20. The offering totals $10.0M. Industry: Other Health Care.

Offering

• Filed: 2024-03-20
• Form: D
• Accession: 0002016398-24-000001
• Industry: Other Health Care
• Exemptions: 06c
• Total offering: $10.0M
• Remaining: $10.0M
• Minimum investment: $50K
• Security types: equity
• Revenue range: Not Applicable
• SEC file number: 021-508159

Issuer

• Name: LexaGene Life Sciences RD Investors, LLC
• CIK: 0002016398
• Entity type: Limited Liability Company
• Jurisdiction: DELAWARE
• Incorporated: 2023
• Address: 3811 TURTLE CREEK BOULEVARD, DALLAS, TX, 75219
• Phone: 2146514050

Officers, directors & promoters (1)

More

• CIK 2016398 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search